MAY 13, 2015 3:00 PM PDT

Using the network architecture of eQTLs to understand complex traits

Speaker
  • Postdoctoral Research Fellow, Dana Farber Cancer Institute/Harvard University
    Biography
      John Platig received his PhD in Physics from the University of Maryland. His thesis focused on the applications of complex network methods to biological data sets, with an emphasis on understanding how errors in edge identification affect network properties. In conjunction with his physics training, he was a Cancer Research Training Fellow at the National Cancer Institute, working to identify potential therapeutic targets from a reconstructed gene regulatory network in Diffuse Large B Cell Lymphoma. In 2013 John started as postdoctoral fellow with John Quackenbush at the Dana-Farber Cancer Institute. He is currently working on network inference and clustering methods to better understand genetic and other factors that drive phenotypes.

    Abstract

    Genome Wide Association Studies (GWAS) and eQTL analyses are producing huge numbers of associations and show no signs of slowing. There are now more than 8,500 SNPs associated with more than 350 complex traits reported in the NHGRI GWAS Catalog. However, interpreting these associations collectively in a functional context remains a challenge. Using genotyping and gene expression data from 163 lung tissue samples in a lower respiratory disease study, we calculated eQTL associations between SNPs and genes and cast significant associations as links in a bipartite network. We identified biological function by focusing on densely linked communities, which comprise groups of SNPs associated with groups of genes. By investigating the intermediate scale of network organization, we found GWAS SNPs enriched at the cores of these communities, including GWAS hits for COPD, asthma, and pulmonary function, among others. We believe these methods are widely applicable to any data set that can be represented as a bipartite network with a giant connected component.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    OCT 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources